CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
GORE® Ascending Stent Graftdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02380716
NCT02380716N/ACompleted

ARISE: Evaluation of the GORE® Ascending Stent Graft in the Treatment of DeBakey Type I/II Aortic Dissection

W.L.Gore & Associates·interventional·Posted Mar 5, 2015·Updated May 13, 2026

In Brief

A clinical study evaluating GORE® Ascending Stent Graft for Aortic Dissection. Completed, enrolled 21 participants across 1 site.

Detailed Summary

Assess the feasibility of the treatment of DeBakey Type I/II aortic dissections with the GORE® Ascending Stent Graft

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 5, 2015
Enrollment StartAug 1, 2015
Primary CompletionFeb 26, 2021
Study CompletionApr 1, 2026
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 11.3 years ago

Interventions

GORE® Ascending Stent Graftdevice